179 related articles for article (PubMed ID: 2576232)
1. [A pharmacological analysis of the anxiolytic action of derivations of benzodiazepine, GABA and beta-carboline in various tests of tension reaction].
Talalaenko AN
Farmakol Toksikol; 1989; 52(6):26-9. PubMed ID: 2576232
[TBL] [Abstract][Full Text] [Related]
2. [The neurochemical profile of the dorsal hippocampus and the antiaversive effects of anxiolytics in different models of anxiety in rats].
Talalaenko AN
Zh Vyssh Nerv Deiat Im I P Pavlova; 1993; 43(3):621-6. PubMed ID: 8103252
[TBL] [Abstract][Full Text] [Related]
3. [The neurochemical profile of the septal nucleus accumbens in the anxiolytic action of tranquilizers on different models of anxiety].
Talalaenko AN; Panfilov VIu; Vozdigan SA; Pokramovich AI; Markova OP; Okhrimenko SV
Eksp Klin Farmakol; 1997; 60(4):7-9. PubMed ID: 9376765
[TBL] [Abstract][Full Text] [Related]
4. [The mechanisms of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives, serotonin agonists].
Talalaenko AN; Kharin NA
Eksp Klin Farmakol; 1993; 56(2):11-3. PubMed ID: 8102289
[TBL] [Abstract][Full Text] [Related]
5. [The role of the neurochemical mechanisms of the medial raphe nucleus in anxiety states formed by various aversive actions].
Talalaenko AN; Getmanov VV; Gritsiuk VP; Onishak OD
Biull Eksp Biol Med; 1989 Sep; 108(9):261-3. PubMed ID: 2575405
[TBL] [Abstract][Full Text] [Related]
6. [The characteristics of the anxiolytic action of benzodiazepine and non-benzodiazepine tranquilizers in different tests of anxiety].
Talalaenko AN; Abramets II; Stakhovskiĭ IuV; Shekhovtsov AA; Shevchenko SL; Chernikov AV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):144-51. PubMed ID: 1349783
[TBL] [Abstract][Full Text] [Related]
7. [Neurochemical features of the ventral pallidum in realization of the antiaversive effects of anxiolytics in different models of anxiety].
Talalaenko AN; Pankrat'ev DV; Bulgakova NP
Eksp Klin Farmakol; 2006; 69(1):6-11. PubMed ID: 16579051
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of the anxiolytic action of benzodiazepine and GABA derivatives on experimentally modelled anxiety states].
Talalaenko AN; Zin'kovskaia LIa
Farmakol Toksikol; 1988; 51(4):20-2. PubMed ID: 2903833
[TBL] [Abstract][Full Text] [Related]
9. [The role of neurochemical mechanisms of the dorsal raphe nucleus in various models of anxiety states in rats].
Talalaenko AN
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(6):1124-8. PubMed ID: 2576490
[TBL] [Abstract][Full Text] [Related]
10. [The neurochemical profile of the caudate nucleus in the anxiolytic action of benzodiazepine and nonbenzodiazepine tranquilizers on different models of anxiety].
Talalaenko AN; Gordienko DV; Markova OP
Eksp Klin Farmakol; 2000; 63(1):14-8. PubMed ID: 10763103
[TBL] [Abstract][Full Text] [Related]
11. [The neurochemical mechanisms of the central amygdaloid nucleus and the anxiolytic action of tranquilizers in different models of anxiety states].
Talalaenko AN; Krivobok GK; Babiĭ IuV; Bogdanov VA; Perch NN
Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(6):1116-23. PubMed ID: 7879435
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG).
Vignes M; Maurice T; Lanté F; Nedjar M; Thethi K; Guiramand J; Récasens M
Brain Res; 2006 Sep; 1110(1):102-15. PubMed ID: 16859659
[TBL] [Abstract][Full Text] [Related]
13. [Effect of benzodiazepine and GABA derivatives on the energy metabolism indices in brain edema].
Novikov VE; Kozlov SN; Iasnetsov VS
Farmakol Toksikol; 1984; 47(3):35-8. PubMed ID: 6145621
[TBL] [Abstract][Full Text] [Related]
14. [Monoamine, GABA, and glutamergic mechanisms of the anterior hypothalamus in anti-aversive effects of sedative and selective drugs in various models of anxiety].
Talalaenko AN; Gordienko DV; Markova OP; Goncharenko NV; Pankrat'ev DV
Eksp Klin Farmakol; 2001; 64(2):20-4. PubMed ID: 11548441
[TBL] [Abstract][Full Text] [Related]
15. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
16. [The functional role of monoaminergic and amino acid-ergic mechanisms of the locus coeruleus in anxiety from different aversive origins].
Talalaenko AN; Stakhovskiĭ IuV; Bogdanov BA; Babiĭ IuV; Perch NN
Biull Eksp Biol Med; 1993 Jun; 115(6):634-6. PubMed ID: 8104050
[TBL] [Abstract][Full Text] [Related]
17. [Anxiolytic action of beta-carbolines in rats].
Burov IuV; Orekhov SN; Vedernikova NN
Biull Eksp Biol Med; 1985 Apr; 99(4):453-5. PubMed ID: 2859060
[TBL] [Abstract][Full Text] [Related]
18. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
dos Reis LM; Canto-de-Souza A
Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine, beta-carboline, and barbiturate actions on GABA responses.
Macdonald RL; Weddle MG; Gross RA
Adv Biochem Psychopharmacol; 1986; 41():67-78. PubMed ID: 2874695
[No Abstract] [Full Text] [Related]
20. Bidirectional modulation of GABA function by beta-carbolines.
Jensen LH; Petersen EN; Honoré T; Drejer J
Adv Biochem Psychopharmacol; 1986; 41():79-89. PubMed ID: 2874696
[No Abstract] [Full Text] [Related]
[Next] [New Search]
